Published in Women's Health Weekly, May 31st, 1999
The recommendation issued May 18, 1999, by the American Society of Clinical Oncology was based largely on earlier research showing that tamoxifen - available since 1978 as a treatment for breast cancer - can also cut women's risk of developing the disease almost in half.
The statement said tamoxifen "may be offered" to women who have at least a 1.7 percent risk of getting breast cancer over the next five years. That is considered a modestly increased risk. About 29 million...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.